|A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma||
||921||All||18 Years and older (Adult, Senior)||NCT00943826||BO21990
|June 29, 2009||February 28, 2013||September 9, 2015||July 22, 2009||September 25, 2017||May 20, 2013||
|2||NCT02898012||Completed||Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status||
||Other / Industry||
||70||All||70 Years and older (Senior)||NCT02898012||P081213||ATAG||October 2010||May 2013||June 2013||September 13, 2016||September 13, 2016||
† Study has passed its completion date and status has not been verified in more than two years.